Safety and efficacy of GST-HG141, a novel HBV capsid assembly modulator, for the treatment of chronic hepatitis B patients with low-level viremia: a randomized, double-blind, placebo-controlled, multicenter phase II studyChong Wang, Junqi Niu, Haibing Gao et al.|EClinicalMedicine|2025Cited by 7